# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001737287-23-000091
Filing Date
2023-11-02
Accepted
2023-11-02 16:06:51
Documents
70
Period of Report
2023-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | allo-20230930.htm iXBRL | 10-Q | 1401643
2 | EX-5.1 | allo-20230930xex51.htm | EX-5.1 | 16376
3 | EX-10.1 | allo-20230930xex101.htm | EX-10.1 | 152082
4 | EX-10.2 | allo-20230930xex102.htm | EX-10.2 | 147015
5 | EX-10.3 | allo-20230930xex103.htm | EX-10.3 | 835177
6 | EX-10.4 | allo-20230930xex104.htm | EX-10.4 | 34707
7 | EX-31.1 | allo-20230930xex311.htm | EX-31.1 | 9788
8 | EX-31.2 | allo-20230930xex312.htm | EX-31.2 | 9753
9 | EX-32.1 | allo-20230930xex321.htm | EX-32.1 | 7017
15 |  | allogenefooter.jpg | GRAPHIC | 3922
16 |  | allogenelogo.jpg | GRAPHIC | 14655
17 |  | cooleya02a.jpg | GRAPHIC | 10201
| Complete submission text file | 0001737287-23-000091.txt |  | 7976779

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
10 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | allo-20230930.xsd | EX-101.SCH | 48275
11 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | allo-20230930_cal.xml | EX-101.CAL | 51630
12 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | allo-20230930_def.xml | EX-101.DEF | 256798
13 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | allo-20230930_lab.xml | EX-101.LAB | 631891
14 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | allo-20230930_pre.xml | EX-101.PRE | 388960
64 | EXTRACTED XBRL INSTANCE DOCUMENT | allo-20230930_htm.xml | XML | 778333

Mailing Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 457-2700
Allogene Therapeutics, Inc. (Filer) CIK: 0001737287 (see all company filings)

EIN.: 823562771 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38693 | Film No.: 231372258
SIC: 2836 Biological Products, (No Diagnostic Substances)